Cefepime overdoseNeurological disorders in elderly patients with renal impairment: 3 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2009年 / 1272卷 / 1期
关键词：
Chronic Kidney Disease; Kidney Disease; Neurological Disorder; Renal Impairment; Blood Concentration;
D O I：
10.2165/00128415-200912720-00033
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 11
相关论文
共 50 条
  • [41] Bortezomib overcomes the negative prognostic impact of renal impairment in a newly diagnosed elderly patient with multiple myeloma: A case report
    Wu, Tao
    Zhou, Jinmao
    Wang, Cunbang
    Wang, Binbin
    Zhang, Shuting
    Bai, Hai
    ONCOLOGY LETTERS, 2017, 14 (06) : 7318 - 7322
  • [42] Prevalence of cardiovascular risk factors and their association with renal impairment in elderly patients with type 2 diabetes mellitus in a Nigerian tertiary hospital: a cross-sectional study
    Junaid, Oladimeji Adedeji
    Ojo, Olubukola Ayoola
    Adejumo, Oluseyi Ademola
    Junaid, Folorunsho Mansally
    Owolade, Sunday Samson
    Ojo, Olalekan Ezekiel
    Kolawole, Babatope Ayodeji
    Ikem, Temidayo Rosemary
    PAN AFRICAN MEDICAL JOURNAL, 2022, 42
  • [43] Safety and efficacy of thromboprophylaxis with fondaparinux in elderly acutely ill medical patients with renal impairment: a retrospective single center study
    Silvestri, Federico
    Pasca, Samantha
    Zaramella, Marco
    Labombarda, Antonella
    Barbi, Andrea
    Desideri, Mauro
    Guidi, Paolo
    Rogato, Adolfo
    Bergamo, Matteo
    Barillari, Giovanni
    ITALIAN JOURNAL OF MEDICINE, 2013, 7 (04) : 287 - 292
  • [44] PHARMACOKINETICS OF ENOXACIN AND ITS METABOLITE 3-OXO-ENOXACIN IN PATIENTS WITH SEVERE RENAL IMPAIRMENT
    DEUBER, HJ
    OHRISCH, G
    SCHULZ, W
    METZ, R
    MUTH, P
    SORGEL, F
    KRAEFT, H
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1993, 22 (03) : 104 - 109
  • [45] Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study
    San-Miguel, J. F.
    Richardson, P. G.
    Sonneveld, P.
    Schuster, M. W.
    Irwin, D.
    Stadtmauer, E. A.
    Facon, T.
    Harousseau, J-L
    Ben-Yehuda, D.
    Lonial, S.
    Goldschmidt, H.
    Reece, D.
    Blade, J.
    Boccadoro, M.
    Cavenagh, J. D.
    Neuwirth, R.
    Boral, A. L.
    Esseltine, D-L
    Anderson, K. C.
    LEUKEMIA, 2008, 22 (04) : 842 - 849
  • [46] Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study
    J F San-Miguel
    P G Richardson
    P Sonneveld
    M W Schuster
    D Irwin
    E A Stadtmauer
    T Facon
    J-L Harousseau
    D Ben-Yehuda
    S Lonial
    H Goldschmidt
    D Reece
    J Bladé
    M Boccadoro
    J D Cavenagh
    R Neuwirth
    A L Boral
    D-L Esseltine
    K C Anderson
    Leukemia, 2008, 22 : 842 - 849
  • [47] Evaluation of long-term efficacy and tolerability of irbesartan in elderly hypertensive patients with renal impairment in an open-label study
    De Rosa, ML
    Cardace, P
    Rossi, M
    Baiano, A
    de Cristofaro, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2002, 63 (03): : 201 - 215
  • [48] Dosage Optimization Using Physiologically Based Pharmacokinetic Modeling for Pediatric Patients with Renal Impairment: A Case Study of Meropenem
    Rahim, Najia
    Sarfraz, Muhammad
    Bello, Abubakar
    Naqvi, Syed Baqir Shyum
    AAPS PHARMSCITECH, 2025, 26 (01):
  • [49] No accumulation of the peak anti-factor Xa activity of tinzaparin in elderly patients with moderate-to-severe renal impairment: the IRIS substudy
    Siguret, V.
    Gouin-Thibault, I.
    Pautas, E.
    Leizorovicz, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (10) : 1966 - 1972
  • [50] Simvastatin/sitagliptin interactionFirst reports of sitagliptin-induced acute renal failure and of an interaction with simvastatin, leading to rhabdomyolysis in an elderly patient: case report
    Reactions Weekly, 2008, 1209 (1) : 28 - 28
12345